Clinical trials

  • GEMCITABINE for Intrahepatic cholangiocarcinoma
  • ENTRECTINIB for Non-small cell lung cancer (ROS1 gene rearrangement)
  • DEFEROXAMINE MESILATE for Pulmonary aspergillosis|Allergic bronchopulmonary aspergillosis (ABPA)
  • Enzalutamide for Prostate cancer | Metastatic prostate cancer
  • 225Ac-PSMA-Trillium (BAY 3563254) for Metastatic castration-resistant prostate cancer (mCRPC)
  • TULISOKIBART for Crohn's disease
  • ELRITERCEPT for Myelodysplastic syndrome | Anemia
  • AVALGLUCOSIDASE ALFA for Late-onset Pompe disease|Pompe disease
  • FINERENONE for Chronic kidney disease
  • TAFASITAMAB for Diffuse large B-cell lymphoma (DLBCL)|Relapsed or refractory diffuse large B-cell lymphoma
  • LUTETIUM (177LU) OXODOTREOTIDE for Gastroenteropancreatic neuroendocrine tumour (GEP-NET)|Neuroendocrine tumour
  • DS-3939A for Metastatic solid tumor|Advanced solid tumor